Your session is about to expire
← Back to Search
Homeopathic
1 for Allergy or Hay Fever (SMAN Trial)
Phase 4
Waitlist Available
Led By Martha White, MD
Research Sponsored by Strategic Biosciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up twice daily for 28 days
Awards & highlights
SMAN Trial Summary
The purpose of this study is to demonstrate the equivalence of two homeopathic capsaicin containing nasal sprays (Sinol-M™ and Sinol) in patients with nasal congestion due to allergic rhinitis.
Eligible Conditions
- Allergy or Hay Fever
SMAN Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ twice daily for 28 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~twice daily for 28 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Daily Total Nasal Symptom Score (congestion, rhinorrhea, sneezing, nasal itching)
Secondary outcome measures
Number of sprays of study drug used
Side effects data
From 2016 Phase 4 trial • 120 Patients • NCT0312440765%
Application site pain
18%
Application site pruritus
3%
Application site erythema
100%
80%
60%
40%
20%
0%
Study treatment Arm
QD-Active
QD-Vehicle
BID-Active
BID-Vehicle
SMAN Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Sinol-M
Group II: 2Active Control1 Intervention
Sinol
Find a Location
Who is running the clinical trial?
Strategic BiosciencesLead Sponsor
Martha White, MDPrincipal InvestigatorInstitute for Allergy and Asthma
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger